Table 2.
Extracted data from the 24 non-comparative studies reviewed. All data in parentheses is either SD of mean value or range of values. RC – Retrospective cohort, PC – Prospective cohort.
| Characteristic and Outcomes of Non-Comparative Studies | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||||||||
| Study | Intervention | Study | MINORS Score | # of patients | # of males | Average Age (yrs) | Type of CP | GMFCS Level | Mean #of procedures | Mean follow up (mo) | KFIC (°) | MKES t(°) | MKFSw (°) | TKE (°) | Cadence (steps/min) | Walking Speed (m/s) | Stride Length (m) | Mean Pelvic Tilt (°) | Popliteal Angle (°) | |
| Adolfsen [26] | HSL, RFT, and GSL | RC | 8 | 15 | 8.5 (2) | 3 | 23 | Pre Post |
37 (7) 24 (10) |
24 (5) 16 (11) |
NS NS |
NS NS |
57 (10) 42 (10) |
|||||||
| Carney [30] | HSL and RFT, SEMLS | RC | 8 | 23 | 14 | 11.75 (2.5) | I-III | 3.2 | > 12 | Pre Post |
26 (13) 12 (14) |
57 (9) 50 (12) |
31 (11) 67 (14) |
|||||||
| Carney [13] | HSL alone | RC | 8 | 16 | 8 | 12 (8–16) | I-III | 1 | >12 | Pre Post |
33 (10) 10 (13) |
64 (9) 48 (11) |
31 (12) 39 (12) |
|||||||
| Corry [31] | Botox injection of Hamstrings | PC | 13 | 10 | 3 | 7.2 (4–11) | 1 | 3 | Pre Post |
NS NS |
NS NS |
NS NS |
NS NS |
NS NS |
NS NS |
20 (6.5) 25 (7.9) |
64 (12.8) 47 (7.3) |
|||
| Damiano [34] | Extensor Strengthening | PC | 15 | 8 | 3 | 7.78 (2.6) | SD | I-III | 2 | Pre Post |
NS NS |
NS NS |
NS NS |
NS NS |
||||||
| Damiano [33] | HSL in SEMLS | PC | 19 | 13 | 9.46 (3.2) | 9 | Pre Post |
30.9 39 |
NS NS |
NS NS |
0.71 0.84 |
|||||||||
| Damiano [20] | Quadriceps Strengthening | PC | 12 | 14 | 10 | 9.1 (2.5) | SD | 1.2 | Pre Post |
32 (10) 27 (15) |
NS NS |
NS NS |
NS NS |
NS NS |
0.74 (0.2) 0.82 (0.15) |
|||||
| de Morais [38] | DFEO in SEMLS | RC | 7 | 12 | 5 | 13.1 (9.1–19.9) | SD | II-IV | 5.2 | 27 | Pre Post |
43.56 () 22.29 () |
12 21.9 |
|||||||
| Gordon [46] | Percutaneous medial HSL | RC | 8 | 48 | 9.45 | SD, SH, SQ | I-III | 33.8 | Pre Post |
26.6 (9.9) 20.1 (12.3) |
NS NS |
NS NS |
0.9 (0.34) 1.0 (0.27) |
0.86 (0.34) 0.99 (0.2) |
NS NS |
49.6 (11.9) 41.5 (17) |
||||
| Hadley [47] | RFT and HSL in SEMLS | RC | 7 | 24 | 11 (5–18) | SD, SH | >3 | Pre Post |
23.2 3.2 |
NS NS |
30.7 46.1 |
|||||||||
| Koca [54] | RFT and HSL in SEMLS | RC | 8 | 19 | 9 | 12.1 (11–27) | SD | 5.2 | 6.3 | Pre Post |
43.8 (4.1) 20.1 (2.1) |
40.5 (NR) 18 (7) |
NS NS |
14 (2.1) 32 (1.4) |
112 87 |
0.42 (0.1) 0.56 (0.2) |
0.41 (0.06) 0.57 (0.08) |
61 (5.2) 22 (3.8) |
||
| Lovejoy [55] | HSL during SEMLS (Med and Lat) | RC | 9 | 38 | 25 | 12.33 (4.6–19.6) | SD | 21.6 | Pre Post |
43.9 (12.8) 26.8 (10.8) |
51.5 (12) 39 (10.6) |
41.2 (10.5) 26.6 (9.9) |
57.8 (11.1) 37.2 (10.3) |
|||||||
| Ma [56] | HST/HSL | RC | 9 | 19 | 10 | 9 (5–14) | SD, SQ | III-IV | 6.7 | 25.2 | Pre Post |
39 (8) 22 (7) |
39 (8) 22 (7) |
70 (9.2) 42.6 (9.5) |
||||||
| Metaxiotis [57] | CBM (RFT, HST, GST) | PC | 14 | 20 | 13 | 11.5 (5.6–17.0) | SD | 12.05 | 37.2 | Pre Post |
41.5 (15.4) 19.1 (12.8) |
28.7 (23.4) 6.2 (14.5) |
58.3 (12.9) 51.4 (8.1) |
31.9 (15.2) 45.2 (13.9) |
118 (25) 103 (24) |
NS NS |
0.6 (0.14) 0.67 (0.13) |
53.6 (13.6) 25 (12.6) |
||
| Ounpuu [59] | HSL, GSL, RFT in SEMLS | RC | 12 | 22 | 11 | 8 (2.7) | I-III | 4.7 | 132 | Pre Post |
35 (9) 24 (9) |
NS NS |
NS NS |
139 (23) 115 (15) |
NS NS |
0.79 (0.22) 0.98 (0.23) |
NS NS |
|||
| Papadonikolakis [60] | Botox injection of hamstrings | PC | 20 | 14 | 11 (217) | SH, SQ, SD | 49 | Pre Post |
NS NS |
14 (9) 10 (9) |
NS NS |
NS NS |
NS NS |
NS NS |
L - 0.70 (.2) L - 0.76 (.2) |
|||||
| Rodda [64] | SEMLS for severe crouch | RC | 11 | 10 | 7 | 12 (7.9–16.2) | SD | II-III | 7 | 60 | Pre Post |
52 (7) 26 (10) |
44 (9) 17 (11) |
14 (12) 24 (9) |
NS NS |
|||||
| Rogozinski [65] | FRAFO | PC | 9 | 27 | 18 | 12.4 (2.4) |
SD, ST, SQ | II-III | Bare AFO |
29 (14.3) 18 (14.4) |
NS NS |
.72 (.25) .83 (.19) |
.84 (.19) 1.00 (.17) |
|||||||
| Sossai [67] | PTS in SEMLS | RC | 15 | 24 | 16 | 16.1 (5.8) | SD | II-III | 4.6 | 21.8 | Pre Post |
51.1 (18.2) 32.4 (10.8) |
32.4 (22.8) 20.5 (13.9) |
71.9 (16.5) 57.8 (10) |
55 (19) 37.6 (12.2) |
14.1 (6.8) 21.6 (6.6) |
||||
| Steele [69] | Strength Training | MA | 12 | 30 | 13.7 (3.8) | I-III | 2 | Pre Post |
NS NS |
NS NS |
||||||||||
| Sung [70] | HSL in SEMLS | RC | 10 | 29 | 18 | 8.3 (5.1–16.3) | SD | I-III | 9.1 | 141.6 | Pre Post |
31.1 (12.7) 23.6 (8.1) |
NS NS |
31.4 (12.7) 23 (7.8) |
NS NS |
NS NS |
0.71 (.25) 0.87 (.23) |
NS NS |
||
| Thompson [19] | Botox injection of hamstrings | PC | 11 | 10 | 7.2 (4–12) | SQ, SD | 0.5 | Pre Post |
NS NS |
26 12.42 |
NS NS |
|||||||||
| van der Linden [73] | HSL during SEMLS (Med and Lat) | RC | 8 | 18 | 11 (6–20) | SH, SD | 13 | Pre Post |
42 (12) 30 (12) |
32 (13) 20 (14) |
63 (12) 54 (10) |
30 (9) 34 (11) |
60 (9) 56 (10) |
NS NS |
NS NS |
NS NS |
||||
| Westwell [74] | HSL in SEMLS | RC | 9 | 21 | 9 | 18.9 (14.2–29.3) | SH, SD | I-IV | 13.2 | Pre Post |
32 (15) 22 (13) |
36 (12) 42 (16) |
58 (12) 31 (18) |
|||||||